A Phase 1b, Dose Escalation and Expansion Study of Lemzoparlimab with or without Dexamethasone and in Combination With Anti- Myeloma Regimens for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

  • Spencer, Andrew (Primary Chief Investigator (PCI))
  • Keane, Colm (Chief Investigator (CI))
  • Murphy, Nicholas (Chief Investigator (CI))
  • Hocking, Jay (Chief Investigator (CI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

Effective start/end date21/02/2231/12/27


  • Malignant Haematology
  • Multiple myeloma
  • Clinical trial